SHR0410

N/A

Report date: 2022/05/26 14:40:04
NME

Base Information

Drug NameSHR0410
Drug Alias NameSHR-0410
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor agonists
TargetsKappa opioid receptor
Therapy Area/IndicationsAcute PainPainPain, Postoperative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co LtdChengdu Suncadia Medicine Co LtdShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Suncadia Medicine Co LtdShanghai Hengrui Pharmaceutical Co LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesAtridia Pty Ltd
Active IndicationsPainPain, Postoperative
Inactive IndicationsAcute PainPruritus

Other Information

ATC CodeN/A
Related LinksN/A